Medscape – Psychotropic Medications Linked to Serious Adverse Drug Reactions in Children

Psychotropic medications are associated with adverse drug reactions (ADRs), many of which are serious, in children younger than 17 years, according to a new database study from Danish researchers. Results also showed that all but one of the psychotropic-related ADRs for children between the ages of birth and 2 years were serious, including birth defects such as neonatal withdrawal syndrome, ventricular septal defects, and premature labor.

INFOWARS.COM — Madhouse Medical Tyranny: When Health Becomes Sickness

Dictatorships know that the battle for complete control is ultimately won or lost in the minds of the target population. As the oppression advances, it tends to move from propaganda mind control to the direct intervention into the mind via pharmaceuticals. We are now seeing the overt global coordination of the psychiatry profession to convince every resident of planet Earth that all clear thinking, healthy living, and wholesome innocence is some kind of disorder that needs to be corrected (suppressed) with drugs to render zombie-like those whose instincts afford them the ability of discernment.

Prescription Pill-Popping By Far a Leading Killer as Florida’s Drug Deaths Spike 20%

Ken Kramer, a researcher with the Citizens Commission on Human Rights of Florida, says the numbers underestimate the extent of the problem, because medical examiners do not track deaths attributed to antipsychotic drugs or to antidepressants, both of which carry black-box or black-label warnings. The warnings on antidepressants, required by the Food and Drug Administration, state that the drugs increase the risk of suicidal thinking and behavior in children, adolescents and young adults up to age 24. (Antidepressants include Paxil, Prozac, Zoloft, Effexor, Lexapro and Celexa.)

Senator Grassley Investigates Big Pharma’s Treatment of Drug Company Whistleblowers Who File Complaints

U.S. Senator Charles Grassley asked 16 drugmakers, including Pfizer Inc., AstraZeneca Plc and Eli Lilly & Co., to reveal how they treat whistleblowers who file complaints under the False Claims Act. Grassley, an Iowa Republican, sent letters June 28 that posed eight questions such as how companies notify employees of the law, how they treat whistleblowers and what changes they have made in response to a 2009 law extending anti-retaliation protections.